Tango Therapeutics, Inc. - Common Stock (TNGX)

Historical Holders from Q3 2021 to Q3 2025

Symbol
TNGX on Nasdaq
CUSIP
87583X109
Type / Class
Equity / Common Stock
Shares outstanding
135M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
140M
Holdings value
$1.18B
% of all portfolios
0.007%
Grand Portfolio weight change
+0%
Number of holders
141
Number of buys
84
Number of sells
-45
Average Value change %
0%
Average buys %
+0%
Average sells %
-0.002%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Tango Therapeutics, Inc. - Common Stock (TNGX)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Farallon Capital Partners, L.P. 9.7% +16.3% $90.4M $13.4M 10.8M +17.5% Dapice Joshua J. Sep 30, 2025
EcoR1 Capital, LLC 9.9% $15.5M 10.6M EcoR1 Capital, LLC Dec 31, 2024
TCG Crossover GP II, LLC 6.3% $71.7M 8.54M TCG Crossover GP II, LLC Sep 30, 2025
Third Rock Ventures IV, L.P. 5.85% -16% $62.8M -$12M 7.87M -16% Third Rock Ventures IV, L.P. Nov 19, 2025
Woodline Partners LP 5.6% $35.8M 6.03M Woodline Partners LP Jun 30, 2025
Invus Global Management, LLC 5.3% $40.6M 5.88M Raymond Debbane Sep 19, 2025
BlackRock, Inc. 5% $27.9M 5.46M BlackRock, Inc. Jun 30, 2025
Adage Capital Management, L.P. 2.26% -63.8% $21.1M -$28.5M 2.51M -57.5% Adage Capital Management, L.P. Sep 30, 2025
FMR LLC 0% $19.6K 13.4K FMR LLC Nov 29, 2024

Institutional Holders of Tango Therapeutics, Inc. - Common Stock (TNGX)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 140M $1.18B +$109M $8.40 141
2025 Q2 127M $651M +$113M $5.12 114
2025 Q1 107M $147M -$1.5M $1.37 119
2024 Q4 106M $329M -$121M $3.09 134
2024 Q3 101M $781M -$3.59M $7.70 119
2024 Q2 98.6M $846M +$2.65M $8.58 116
2024 Q1 98.4M $781M +$30.8M $7.94 124
2023 Q4 93.6M $927M +$41.1M $9.90 118
2023 Q3 88.8M $1B +$237M $11.26 99
2023 Q2 68.3M $227M -$7.69M $3.32 89
2023 Q1 69.8M $276M +$1.73M $3.95 90
2022 Q4 68.7M $498M +$12.9M $7.25 82
2022 Q3 68.1M $247M -$12.1M $3.62 85
2022 Q2 70.5M $319M -$11.1M $4.53 76
2022 Q1 69.7M $528M +$13.4M $7.58 70
2021 Q4 67.8M $741M +$24.9M $10.94 57
2021 Q3 65.5M $845M +$845M $12.93 45